• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液成分中的阳性(1→3)-β-D-葡聚糖以及用于血液处理的深层膜过滤器中(1→3)-β-D-葡聚糖的释放。

Positive (1-->3)-beta-D-glucan in blood components and release of (1-->3)-beta-D-glucan from depth-type membrane filters for blood processing.

作者信息

Usami Makoto, Ohata Atsushi, Horiuchi Takeshi, Nagasawa Koichi, Wakabayashi Toshio, Tanaka Shigenori

机构信息

Division of Surgical Metabolism, Faculty of Health Sciences, Kobe University School of Medicine, Japan.

出版信息

Transfusion. 2002 Sep;42(9):1189-95. doi: 10.1046/j.1537-2995.2002.00162.x.

DOI:10.1046/j.1537-2995.2002.00162.x
PMID:12430677
Abstract

BACKGROUND

The false-positive elevation of plasma (1-->3)-beta-D-glucan level, a serodiagnostic test for deep-seated mycosis, is suspected in patients administered with blood components.

STUDY DESIGN AND METHODS

(1-->3)-beta-D-Glucan and endotoxin levels in blood components consisting of 12 albumins, 8 immunoglobulins, and 3 blood coagulation factors were measured by fungal infection tests (Fungitec G-test, Seikagaku Co.; the Wako WB003 test, Wako Pure Chemical Industries; and the Endospec ES test, Seikagaku Co.). In vitro release of (1-->3)-beta-D-glucan from the depth-type filters made by cellulose membrane to process blood components was analyzed through an in vitro filtration process as a source of (1-->3)-beta-D-glucan in blood components.

RESULTS

The amounts of (1-->3)-beta-D-glucan in blood components ranged from 0 to 7510 pg per mL in the Fungitec G-test, with wide variations among brands. The positive rates over 20 pg per mL were 75 percent in albumin solutions, 40 percent in blood coagulation factors, and 63 percent in immunoglobulin solutions. (1-->3)-beta-D-Glucan levels released from the five depth filters ranged from 5 to 2516 pg per mL. The (1-->3)-beta-D-glucan level in filtration fluid was decreased by rinsing with distilled water, but rebounded again during the albumin filtration process.

CONCLUSION

Depth filters are considered the source of (1-->3)-beta-D-glucan content in some blood components.

摘要

背景

对于接受血液成分治疗的患者,怀疑其血浆(1→3)-β-D-葡聚糖水平(一种深部真菌病的血清学诊断检测指标)会出现假阳性升高。

研究设计与方法

采用真菌感染检测方法(Fungitec G检测,Seikagaku公司;Wako WB003检测,和光纯药工业株式会社;Endospec ES检测,Seikagaku公司)测定了12种白蛋白、8种免疫球蛋白和3种凝血因子组成的血液成分中的(1→3)-β-D-葡聚糖和内毒素水平。通过体外过滤过程分析了由纤维素膜制成的深度型过滤器向处理血液成分过程中(1→3)-β-D-葡聚糖的体外释放情况,以此作为血液成分中(1→3)-β-D-葡聚糖的来源。

结果

在Fungitec G检测中,血液成分中(1→3)-β-D-葡聚糖的含量范围为每毫升0至7510皮克,不同品牌之间差异很大。每毫升超过20皮克的阳性率在白蛋白溶液中为75%,在凝血因子中为40%,在免疫球蛋白溶液中为63%。从五个深度过滤器释放的(1→3)-β-D-葡聚糖水平范围为每毫升5至2516皮克。用蒸馏水冲洗后,过滤液中的(1→3)-β-D-葡聚糖水平降低,但在白蛋白过滤过程中又再次反弹。

结论

深度过滤器被认为是某些血液成分中(1→3)-β-D-葡聚糖含量的来源。

相似文献

1
Positive (1-->3)-beta-D-glucan in blood components and release of (1-->3)-beta-D-glucan from depth-type membrane filters for blood processing.血液成分中的阳性(1→3)-β-D-葡聚糖以及用于血液处理的深层膜过滤器中(1→3)-β-D-葡聚糖的释放。
Transfusion. 2002 Sep;42(9):1189-95. doi: 10.1046/j.1537-2995.2002.00162.x.
2
Experimental proof of contamination of blood components by (1-->3)-beta-D-glucan caused by filtration with cellulose filters in the manufacturing process.在制造过程中,使用纤维素过滤器过滤导致血液成分被(1→3)-β-D-葡聚糖污染的实验证据。
J Artif Organs. 2003;6(1):49-54. doi: 10.1007/s100470300008.
3
Comparison between Wako-WB003 and Fungitec G tests for detection of (1-->3)-beta-D-glucan in systemic mycosis.用于检测系统性真菌病中(1→3)-β-D-葡聚糖的和光纯药WB003检测法与真菌检测法的比较
J Clin Lab Anal. 1997;11(2):73-7. doi: 10.1002/(sici)1098-2825(1997)11:2<73::aid-jcla1>3.0.co;2-l.
4
[Comparison of four diagnostic methods using clinical blood by measuring (1-->3)-beta-D-glucan].通过测量(1→3)-β-D-葡聚糖对临床血液进行四种诊断方法的比较
Kansenshogaku Zasshi. 2003 Apr;77(4):227-34. doi: 10.11150/kansenshogakuzasshi1970.77.227.
5
Elevation of blood (1-->3)-beta-D-glucan concentrations in hemodialysis patients.血液透析患者血液中(1→3)-β-D-葡聚糖浓度的升高。
Nephron. 2001 Sep;89(1):15-9. doi: 10.1159/000046037.
6
Clinical viability of Fungitell, a new (1→3)-β-D: -glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan.Fungitell,一种新型(1→3)-β-D:-葡聚糖检测试剂盒,用于侵袭性真菌感染诊断的临床可行性,以及与日本其他试剂盒的比较。
J Infect Chemother. 2011 Aug;17(4):473-7. doi: 10.1007/s10156-010-0198-6. Epub 2011 Jan 6.
7
Determination of plasma (1-->3)-beta-D-glucan: a new diagnostic aid to deep mycosis.血浆(1→3)-β-D-葡聚糖的测定:深部真菌病的一种新诊断辅助手段。
J Med Vet Mycol. 1992;30(4):275-80. doi: 10.1080/02681219280000361.
8
[Evaluation of an improved pretreatment method for the measurement of (1-->3)-beta-D-glucan in blood samples].[血液样本中(1→3)-β-D-葡聚糖测量的一种改进预处理方法的评估]
Kansenshogaku Zasshi. 2005 Jul;79(7):433-42. doi: 10.11150/kansenshogakuzasshi1970.79.433.
9
[Clinical evaluation of performance of a new diagnostic method for deep mycosis by measuring beta-glucan concentration in the blood].[通过检测血液中β-葡聚糖浓度对深部真菌病新诊断方法性能的临床评估]
Kansenshogaku Zasshi. 2003 Apr;77(4):219-26. doi: 10.11150/kansenshogakuzasshi1970.77.219.
10
Release of (1-->3)-beta-D-glucan from depth-type membrane filters and their in vitro effects on proinflammatory cytokine production.深度型膜过滤器中(1-->3)-β-D-葡聚糖的释放及其对促炎细胞因子产生的体外影响。
Artif Organs. 2003 Aug;27(8):728-35. doi: 10.1046/j.1525-1594.2003.07137.x.

引用本文的文献

1
Fast, Easy, and Reproducible Fingerprint Methods for Endotoxin Characterization in Nanocellulose and Alginate-Based Hydrogel Scaffolds.快速、简便且可重现的纳米纤维素和海藻酸钠水凝胶支架中内毒素特征分析的指纹图谱方法。
Biomacromolecules. 2024 Oct 14;25(10):6762-6772. doi: 10.1021/acs.biomac.4c00989. Epub 2024 Sep 12.
2
Diagnostic Challenge for Positive 1,3-β-D-Glucan in an Immunocompromised Patient Receiving Intravenous Immunoglobulin Presenting With Respiratory Failure.一名接受静脉注射免疫球蛋白且出现呼吸衰竭的免疫功能低下患者中1,3-β-D-葡聚糖阳性的诊断挑战
Cureus. 2024 May 26;16(5):e61121. doi: 10.7759/cureus.61121. eCollection 2024 May.
3
The influence of continuous renal replacement therapy on 1,3-β-d-glucan levels in critically ill patients: a single-center retrospective propensity score study.
连续性肾脏替代治疗对危重症患者 1,3-β-d-葡聚糖水平的影响:一项单中心回顾性倾向评分研究。
Ren Fail. 2023;45(2):2255680. doi: 10.1080/0886022X.2023.2255680. Epub 2023 Oct 2.
4
pneumonia diagnosed by repeated measurements of β-D-glucan levels.通过重复测量β-D-葡聚糖水平诊断的肺炎
Respir Med Case Rep. 2023 Jul 31;45:101905. doi: 10.1016/j.rmcr.2023.101905. eCollection 2023.
5
Development and Validation of a Risk Score for Predicting Invasive Candidiasis in Intensive Care Unit Patients by Incorporating Clinical Risk Factors and Lymphocyte Subtyping.基于临床风险因素和淋巴细胞分型建立预测 ICU 患者侵袭性念珠菌病风险评分模型的开发和验证。
Front Cell Infect Microbiol. 2022 Apr 27;12:829066. doi: 10.3389/fcimb.2022.829066. eCollection 2022.
6
False-positive Elevation of Beta-D-glucan and Aspergillus Galactomannan Levels Due to Mendelson's Syndrome after Rice Aspiration.误吸大米后因门德尔松综合征导致β-D-葡聚糖和曲霉半乳甘露聚糖水平出现假阳性升高。
Intern Med. 2022 Oct 1;61(19):2935-2939. doi: 10.2169/internalmedicine.8805-21. Epub 2022 Mar 19.
7
Invasive fungal infections in neonates: a review.新生儿侵袭性真菌感染:综述。
Pediatr Res. 2022 Jan;91(2):404-412. doi: 10.1038/s41390-021-01842-7. Epub 2021 Dec 9.
8
Nocardiosis and elevated beta-d-glucan in solid organ transplant recipients.实体器官移植受者中的诺卡菌病与β-d-葡聚糖升高
IDCases. 2021 Oct 27;26:e01322. doi: 10.1016/j.idcr.2021.e01322. eCollection 2021.
9
Challenges with Utilizing the 1,3-Beta-d-Glucan and Galactomannan Assays To Diagnose Invasive Mold Infections in Immunocompromised Children.利用 1,3-β-D-葡聚糖和半乳甘露聚糖检测诊断免疫功能低下儿童侵袭性霉菌感染的挑战。
J Clin Microbiol. 2021 Aug 18;59(9):e0327620. doi: 10.1128/JCM.03276-20.
10
Introduction and clearance of beta-glucan in the downstream processing of monoclonal antibodies.介绍和清除β-葡聚糖在单克隆抗体下游处理中的应用。
Biotechnol Prog. 2021 Jul;37(4):e3149. doi: 10.1002/btpr.3149. Epub 2021 Mar 31.